Elizabeth A. Barrett Uro Gen Pharma Ltd. (URGN) insider trading activity

Elizabeth A. Barrett is Chief Executive Officer of UroGen Pharma Ltd.. Currently has a direct ownership of 326,691 shares of URGN, which is worth approximately $4.95 Million. The most recent transaction as insider was on Jan 31, 2023, when has been sold 18,333 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 327K

0% 3M change

0% 12M change

Total Value Held $4.95 Million

Elizabeth A. Barrett Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 31 2023	BUY Exercise of conversion of derivative security	-	18,333 Added 5.31%	326,691 Ordinary Shares
Jan 31 2022	SELL Open market or private sale	$62,118 $7.58 p/Share	8,195 Reduced 2.59%	308,358 Ordinary Shares
Jan 31 2022	BUY Exercise of conversion of derivative security	-	18,333 Added 5.51%	314,318 Ordinary Shares
Jan 04 2022	SELL Open market or private sale	$429,757 $9.15 p/Share	46,968 Reduced 13.61%	298,220 Ordinary Shares
Jan 03 2022	BUY Exercise of conversion of derivative security	-	105,689 Added 23.44%	345,188 Ordinary Shares
May 19 2021	SELL Payment of exercise price or tax liability	$59,972 $17.51 p/Share	3,425 Reduced 1.41%	239,499 Ordinary Shares
Jan 31 2021	BUY Exercise of conversion of derivative security	-	5,000 Added 2.02%	242,924 Ordinary Shares

Jan 03 2021	BUY Exercise of conversion of derivative security	-	8,807 Added 3.57%	237,924 Ordinary Shares
Dec 14 2020	BUY Open market or private purchase	$185,000 $18.5 p/Share	10,000 Added 4.18%	229,117 Ordinary Shares
Dec 04 2020	BUY Exercise of conversion of derivative security	-	61,652 Added 21.96%	219,117 Ordinary Shares

Also insider at

ALLO

Allogene Therapeutics, Inc. Healthcare

EAB